Biostorage Service Market Size, Share, Growth, and Industry Analysis, By Type (Ambient Storage, Refrigerated and Frozen Storage, Ultra-low Storage, Others), By Application (Life Sciences and Medicine, Hospital, Government and Scientific Research Institutions, Chemical Industry, Others), Regional Insights and Forecast to 2035
Biostorage Service Market Overview
The global Biostorage Service Market is anticipated to grow from USD 641.39 Million in 2026 to USD 2731.72 Million by 2035, registering a CAGR of 17.47% during the forecast period 2026-2035.
The Biostorage Service Market is expanding as pharmaceutical manufacturers, biotechnology companies, hospitals, and research institutions require dependable preservation of biological materials. Global biorepositories maintained more than 3.1 billion biological samples across approximately 5,200 commercial and institutional facilities in 2024. Biostorage services include controlled-temperature preservation, inventory management, sample retrieval, transport coordination, and documentation throughout the biospecimen lifecycle. Growing demand for genomic research, clinical trials, cell therapies, and biological drug development is strengthening the need for specialized storage infrastructure. Organizations increasingly outsource sample management to providers offering validated equipment, continuous temperature monitoring, and secure information systems. Automation and digital inventory platforms are also improving operational consistency. Continued investment in precision medicine, regenerative therapies, and pharmaceutical research supports demand for professional biostorage services.
The USA Biostorage Service Market benefits from advanced biomedical research infrastructure, pharmaceutical development, and extensive clinical trial activity. North America holds approximately 42% of global biostorage capacity, with the United States contributing the largest concentration of specialized facilities. American biotechnology companies increasingly require refrigerated, frozen, and cryogenic storage for clinical specimens, biological materials, and investigational therapies. Azenta, Cryoport, Precision for Medicine, and other service providers support different aspects of biospecimen management. The implementation of automated inventory tracking and continuous temperature monitoring helps facilities maintain sample traceability. Providers are also expanding storage services for cell and gene therapy development. Continued investment in biotechnology research and clinical sample preservation strengthens domestic market opportunities.
Key Findings
- Market Driver: Increasing clinical trial activity and precision medicine research support market expansion, with approximately 68% of clinical trial sponsors outsourcing biological sample preservation to specialist biorepositories.
- Major Market Restraint: High refrigeration and infrastructure expenses restrict smaller providers, with approximately 38% of biostorage companies reporting operational pressure from energy consumption, maintenance, and backup equipment requirements.
- Emerging Trends: Digitalization is transforming sample management, with approximately 51% of biostorage companies adopting automated inventory tracking and related monitoring technologies to improve operational reliability.
- Regional Leadership: North America leads the market with approximately 42% of global biostorage capacity, supported by extensive pharmaceutical research, established biobanks, and specialized cryogenic infrastructure.
- Competitive Landscape: Cryoport holds approximately 11% of global capacity in the referenced competitive ranking, supported by temperature-controlled logistics, bioservices, and expanding clinical therapy support.
- Market Segmentation: Refrigerated and Frozen Storage and Ultra-low Storage each account for approximately 34% of storage capacity, while Life Sciences and Medicine dominates applications with 48% share.
- Recent Development: Cryoport reported 25% growth in its BioStorage and BioServices operations during the second quarter of 2026, reflecting increasing demand for specialized biological material management.
Biostorage Service Market Latest Trends
Automated sample retrieval, digital inventory management, and real-time monitoring are transforming biostorage operations. Approximately 51% of biostorage providers have adopted automation and digital tracking technologies according to the referenced industry analysis. Modern repositories increasingly use barcode identification, RFID systems, and cloud-connected inventory platforms to improve sample visibility. Automated systems can reduce manual handling, support accurate location records, and simplify retrieval from large storage collections. Providers also deploy continuous temperature monitoring with alerts that identify equipment deviations before sample integrity is compromised. Cryogenic automation is particularly important for materials requiring extremely low temperatures. Organizations increasingly prioritize auditable records and dependable chain-of-custody procedures. Continued technological development supports more efficient biological sample management across clinical research and pharmaceutical operations.
Energy efficiency and advanced cryogenic storage represent additional market trends. Approximately 38% of biostorage providers in the reference analysis have adopted energy-efficient refrigeration or backup systems. Maintaining ultra-low temperatures requires dependable electrical infrastructure and continuous equipment supervision. Providers increasingly evaluate efficient freezers, liquid nitrogen systems, and automated maintenance monitoring to reduce operational interruptions. Digital platforms also help operators compare equipment performance and identify developing technical problems. The expansion of cell and gene therapy research is increasing demand for controlled cryogenic conditions. Cryoport and Azenta provide services relevant to specialized biological storage and research operations. Continued development of sustainable facility infrastructure supports investment in dependable temperature-controlled preservation.
Biostorage Service Market Dynamics
Driver
"Clinical research expansion and personalized medicine accelerate biological storage demand."
Increasing clinical trial activity remains an important driver of the Biostorage Service Market. Approximately 68% of clinical trial sponsors in the referenced industry analysis outsource sample preservation to specialized biorepositories. Clinical studies frequently require biological materials to remain available for testing, analysis, and documentation over extended periods. Samples may include blood, plasma, serum, tissue, and other materials requiring controlled environmental conditions. Professional storage providers support inventory records, specimen retrieval, and documented temperature performance. Outsourcing can reduce the need for research organizations to operate every storage facility independently. Demand is particularly important for multicenter studies requiring coordinated sample management. Continued pharmaceutical research and expanding therapeutic development support the growth of specialized biostorage services.
Genomic research and advanced therapeutic development provide another major growth driver. The reference analysis identifies more than 1.6 million genomic datasets added to international research databases annually. Biological specimens supporting genomic investigations must be maintained under conditions appropriate to their intended analytical use. Research institutions increasingly require secure storage combined with consistent sample identification and detailed handling records. Cell and gene therapy development also creates requirements for specialized cryogenic preservation. These applications often involve materials that are highly sensitive to changes in temperature and handling procedures. Providers offering controlled facilities and reliable logistical coordination can strengthen relationships with biotechnology clients. Continued investment in precision medicine supports demand for long-term biological material preservation.
Restraint
"High refrigeration costs and infrastructure requirements limit smaller providers."
Energy consumption and equipment maintenance represent substantial market restraints. Approximately 38% of smaller biostorage providers in the reference analysis report difficulties managing refrigeration and infrastructure expenses. Ultra-low freezers require continuous electrical power, temperature monitoring, and suitable backup arrangements. Facilities must also maintain emergency response procedures to protect samples during equipment failures. Specialized laboratory space, staff training, and technical qualifications contribute additional operating requirements. Smaller providers may struggle to distribute these expenses across limited customer volumes. Energy price volatility can further influence profitability and service pricing. Companies increasingly invest in efficient equipment and preventive maintenance to reduce operational risks. Nevertheless, reliable preservation requires substantial ongoing expenditure.
Capital investment in automated cryogenic infrastructure also creates barriers. The industry analysis indicates that automated cryogenic systems can require approximately 40% higher installation expenditure than conventional storage arrangements. Automated retrieval equipment, specialized enclosures, monitoring networks, and safety features increase facility complexity. Providers must evaluate the expected benefits against available capacity and customer requirements. Advanced systems may improve operational consistency but require specialist maintenance and technical support. Organizations expanding into new locations must also establish qualified utilities, environmental controls, and documented operating procedures. These expenses can discourage smaller companies from entering demanding storage segments. Continued engineering innovation may reduce selected costs, but dependable biological preservation remains capital-intensive.
Opportunity
"Digital biorepositories and advanced therapies create new service opportunities."
Digital sample management offers significant opportunities for biostorage service providers. Approximately 57% of large-scale biorepositories had adopted cloud-integrated management systems by 2024 in the reference analysis. These platforms allow organizations to monitor inventory, review sample locations, and coordinate retrieval activities across facilities. Digital records can support auditing and improve communication between research teams and storage operators. Advanced tracking also reduces dependence on manually maintained inventories. Providers increasingly introduce standardized identifiers and controlled user permissions to protect sensitive sample information. Integration with laboratory management systems can simplify research workflows. Continued investment in digital infrastructure supports opportunities for companies offering dependable biological storage combined with secure information management.
Regenerative medicine and cell therapy development create additional commercial opportunities. Cryoport reported support for 779 clinical trials during the second quarter of 2026, demonstrating the scale of specialized therapeutic supply chain requirements. Cell-based products can require carefully controlled storage and transport conditions to preserve their intended characteristics. Service providers must coordinate collection, processing, cryopreservation, and distribution according to product-specific requirements. These operations demand dependable documentation and collaboration with clinical development teams. Azenta and Cryoport have expanded relevant capabilities through specialized storage and service operations. Continued development of advanced therapies creates opportunities for integrated providers supporting biological materials from research through clinical and commercial activities.
Challenge
"Regulatory differences and sample traceability complicate international operations."
Managing regulatory requirements across jurisdictions remains a major challenge. Approximately 44% of biostorage operators in the reference analysis reported difficulties maintaining consistent compliance across multiple countries. Requirements depend on material type, intended use, applicable laboratory standards, and local regulations. Biological samples may also involve donor consent, privacy obligations, and restrictions on international transfer. Providers must establish procedures appropriate to each customer's activities rather than assuming that one quality framework covers every application. Inconsistent documentation can delay research and create uncertainty about sample suitability. Organizations increasingly invest in quality management systems and staff training to maintain operational consistency. International expansion therefore requires both technical infrastructure and reliable regulatory expertise.
Protecting sample information introduces another important challenge. Approximately 53% of organizations in the reference analysis prioritize complete digital audit trails for biological materials. Biorepositories must record specimen receipt, storage location, movement, retrieval, and final disposition. Missing information can compromise research confidence even when physical storage conditions remain acceptable. Digital platforms also require cybersecurity controls because biospecimen records may contain sensitive research or patient-associated information. Facilities increasingly use controlled access, electronic logging, and regular reconciliation procedures. The challenge becomes more complex when specimens move between multiple storage and research locations. Continued investment in traceable workflows supports dependable service delivery and the long-term integrity of biological collections.
Segmentation Analysis
By Types
Ambient Storage: Ambient Storage accounts for approximately 22% of the global Biostorage Service Market capacity. These services preserve materials that remain stable under controlled room-temperature conditions, including selected dried biological preparations, processed nucleic acids, and reference materials. More than 900 commercial facilities worldwide maintain controlled ambient storage environments according to the reference analysis. Operators monitor temperature, humidity, access, and sample identification to support appropriate preservation. Ambient storage can reduce refrigeration requirements when material stability permits. However, suitability must be established for each sample type and intended application. Continued development of genomics and analytical research supports demand for dependable ambient storage services.
Refrigerated and Frozen Storage: Refrigerated and Frozen Storage represents approximately 34% of global capacity. These services support biological materials requiring temperatures ranging from conventional refrigeration to subzero preservation, depending on the material. More than 1.2 billion biological samples are maintained under refrigerated and frozen conditions worldwide in the referenced analysis. Typical applications include research specimens, selected clinical materials, and pharmaceutical samples. Providers use monitored equipment, documented procedures, and backup systems to reduce exposure to temperature deviations. Modern facilities increasingly adopt automated alerts and energy-efficient refrigeration technologies. Continued growth in clinical trials and pharmaceutical research supports demand for professionally managed refrigerated and frozen storage services.
Ultra-low Storage: Ultra-low Storage accounts for approximately 34% of global biostorage capacity. This category supports sensitive biological materials requiring exceptionally low temperatures, including selected cellular preparations, molecular research samples, and advanced therapy materials. More than 600 new cryogenic storage tanks were installed globally between 2021 and 2024 in the referenced industry analysis. Providers increasingly use automated retrieval, continuous environmental monitoring, and documented handling procedures to protect stored specimens. Temperature requirements depend on the biological material and validated preservation method. Cryoport and Azenta participate in services relevant to ultra-low and cryogenic storage. Continued cell therapy research and long-term biobanking support demand.
Others: Others represents approximately 10% of the storage classification and includes specialized preservation arrangements outside the principal categories. More than 450 facilities worldwide have implemented liquid nitrogen-based cryogenic systems according to the reference analysis. Such facilities may support reproductive materials, cellular preparations, and research specimens requiring specific validated conditions. Operators must manage oxygen displacement risks, nitrogen handling, equipment maintenance, and emergency procedures. Specialized storage also requires accurate identification and suitable retrieval protocols. Providers increasingly develop application-specific services for customers with unusual preservation requirements. Continued innovation in advanced biological research supports this diversified category.
By Applications
Life Sciences and Medicine: Life Sciences and Medicine dominates application demand with approximately 48% market share. Pharmaceutical manufacturers, biotechnology companies, and clinical research organizations require dependable preservation of biological specimens and development materials. Approximately 1.6 billion biological samples are maintained for commercial and academic research according to the reference analysis. Professional biorepositories support clinical trials, genomics, drug development, and regenerative medicine programs. Customers increasingly require comprehensive inventory records, secure retrieval, and reliable environmental monitoring. Outsourcing enables research organizations to access specialist infrastructure without developing every storage capability internally. Continued growth in biological therapies and precision medicine strengthens the segment's leading position.
Hospital: Hospital accounts for approximately 22% of global application demand. Hospitals maintain specimens for diagnostics, clinical research, transplant programs, and medical archives. The reference analysis identifies more than 11,000 hospitals worldwide operating in-house or third-party biological storage arrangements. Appropriate preservation is important for maintaining specimen suitability and enabling subsequent clinical evaluation. Healthcare providers increasingly require reliable identification systems, controlled access, and consistent temperature monitoring. Specialist storage partners can support institutions that lack sufficient internal capacity. Continued development of precision diagnostics and hospital-associated research supports demand for professional biospecimen management services.
Government and Scientific Research Institutions: Government and Scientific Research Institutions represents approximately 18% of global demand. Public research organizations operate biobanks supporting population studies, disease surveillance, genomic investigations, and scientific collaboration. Government-associated biobanking programs operate in more than 40 countries according to the reference analysis. These institutions require consistent specimen identification, long-term preservation, and documented access procedures. Public research collections may also involve detailed consent management and restrictions on data sharing. Professional storage services provide infrastructure and technical expertise for large scientific collections. Continued investment in public health research and national biobanking strengthens demand.
Chemical Industry: Chemical Industry represents approximately 8% of the market. Specialized laboratories require controlled storage for research compounds, analytical reference materials, and selected stability testing applications. Around 400 chemical laboratories worldwide maintain specialized storage infrastructure according to the reference analysis. Storage conditions depend on material characteristics, compatibility, and relevant safety requirements. Providers must distinguish chemical material handling from biological specimen preservation while maintaining appropriate inventory records. Facilities increasingly adopt environmental monitoring and controlled access procedures. Continued research into pharmaceutical compounds and analytical materials creates demand for specialized storage services supporting chemical industry customers.
Others: Others accounts for approximately 4% of global application demand. This category includes additional academic, food testing, and specialized research organizations requiring biological sample preservation. More than 600 universities worldwide operate sample banks supporting different scientific disciplines in the reference analysis. Smaller institutions increasingly consider external storage partnerships when maintaining specialized equipment becomes difficult. Providers can offer standardized inventory systems, controlled conditions, and appropriate retrieval processes. Research requirements vary substantially by specimen and intended use. Continued expansion of multidisciplinary scientific research supports opportunities for flexible biostorage arrangements.
Regional Outlook
North America
North America leads the Biostorage Service Market with approximately 42% of global capacity. The United States and Canada contribute through pharmaceutical research, clinical trials, and established biobanking infrastructure. The region contains more than 900 facilities with advanced inventory management and monitoring capabilities. Azenta, Cryoport, and Precision for Medicine support relevant research and clinical services. Continued investment in cell therapies, genomics, and specialized cryogenic infrastructure strengthens regional demand.
Europe
Europe represents approximately 30% of the five-region market allocation. Germany, the United Kingdom, France, and the Netherlands contribute through established research institutions and pharmaceutical manufacturing. European repositories preserve more than 1.1 billion biological samples according to the reference analysis. Facilities increasingly emphasize energy-efficient refrigeration, ethical sample management, and digital traceability. Continued academic collaboration and advanced therapy development support demand for professional storage services.
Asia-Pacific
Asia-Pacific accounts for approximately 20% of the five-region allocation. China, India, Japan, and South Korea contribute through expanding biotechnology research and national biobanking programs. China maintains more than 800 biobanks according to the reference analysis. Regional institutions increasingly invest in automated sample management and controlled-temperature infrastructure. Continued pharmaceutical research, genomics investment, and clinical development support opportunities for specialist providers.
Middle East and Africa
Middle East and Africa represents approximately 6% of the geographical allocation. Saudi Arabia, the United Arab Emirates, South Africa, and other markets contribute through developing healthcare and genomic research infrastructure. More than 45 specialized facilities were established across the region during the reference review period. Investments in temperature monitoring, reliable refrigeration, and trained personnel support improved sample preservation. Continued public health research and biotechnology development encourage demand.
Rest of the World
Rest of the World represents approximately 2% in the five-region market allocation, primarily covering additional Latin American markets. Brazil, Mexico, Argentina, and neighboring economies contribute through research laboratories, healthcare institutions, and pharmaceutical development. Growing interest in genomic studies and clinical research creates demand for dependable biospecimen preservation. Regional expansion requires appropriate cold infrastructure, trained personnel, and consistent inventory records. Continued scientific investment supports future opportunities.
List of Top Biostorage Service Market Companies
- Azenta
- Cryoport
- Avantor
- Precision for Medicine
- Masy BioServices (Alcami)
- Versiti Clinical Trials
- MilliporeSigma
- SciSafe (BioLife Solutions)
- Kryosphere
- Precision Stability Storage
- Vigilant Bioservices
- BioStorage, LLC
- Tescor
Top 2 Companies with Highest Market Share
- Cryoport: Cryoport holds approximately 11% of global biostorage capacity in the referenced competitive ranking. Its services include temperature-controlled storage, cryogenic logistics, and biological material management supporting clinical and commercial therapy programs.
- Azenta: Azenta accounts for approximately 9% of global biostorage capacity in the same ranking. Its capabilities include automated sample management, biological storage, laboratory services, and biorepository infrastructure supporting pharmaceutical and scientific research organizations.
Investment Analysis and Opportunities
Investment in biostorage infrastructure increasingly focuses on automation, laboratory capacity, and advanced therapy preservation. Approximately 61% of providers in the reference analysis planned to increase digitalization and automation investment. Companies are developing temperature-controlled facilities, automated retrieval systems, and secure inventory platforms. Cryoport and Azenta continue expanding relevant capabilities through specialized service operations. Long-term opportunities depend on dependable infrastructure and sustained biological research demand.
Energy-efficient refrigeration and international research services create additional investment opportunities. The reference analysis identifies approximately 23% growth in investment in digital biorepository management systems during 2024. Providers increasingly evaluate connected monitoring, equipment maintenance tools, and standardized inventory processes. Expansion into developing research markets requires reliable electricity, trained personnel, and appropriate quality procedures. Continued biotechnology investment supports demand for specialized storage partnerships.
New Product Development
Automation and digital tracking remain priorities for biostorage service development. Approximately 70% of major facilities in the reference analysis use cloud-connected platforms supporting sample traceability. Modern systems integrate inventory identification, environmental monitoring, and controlled access. Azenta's acquisition of UK Biocentre in March 2026 expanded its biorepository capabilities. Such investments support more efficient specimen management and international research services.
Advanced cryopreservation services also support product and service development. Cryoport reported approximately 25% growth in BioStorage and BioServices during the second quarter of 2026. The company continued supporting specialized clinical programs requiring dependable material handling. Alcami expanded storage capacity and related laboratory infrastructure during 2026. These developments highlight demand for integrated preservation, sample tracking, and quality-controlled biological material services.
Five Recent Developments
- February 2026 – Azenta Expands Scientific Research Infrastructure Collaboration: Azenta announced a partnership with Frontier Space to support space-based life sciences research infrastructure.
- March 2026 – Azenta Completes Major British Biorepository Acquisition: Azenta completed its acquisition of UK Biocentre Limited, strengthening its biological sample preservation and research service capabilities.
- April 2026 – Avantor Expands American Biomanufacturing Testing Infrastructure: Avantor announced expanded stability and microbial testing capabilities to strengthen laboratory support for biomanufacturing customers.
- June 2026 – Alcami Expands Tennessee Storage And Quality Capabilities: Alcami announced investments in its Tennessee facility to strengthen storage, packaging, and operational quality services.
- June 2026 – Cryoport Secures Advanced Cell Therapy Services Agreement: Cryoport announced that its IntegriCell cryopreservation services were selected by Verismo Therapeutics to support clinical KIR-CAR T-cell programs.
Future Outlook
The Biostorage Service Market is expected to expand through 2035 as clinical trials, genomics, precision medicine, and advanced therapies increase demand for specialized sample preservation. Refrigerated and Frozen Storage and Ultra-low Storage will remain important service categories, while Life Sciences and Medicine will continue leading application demand. North America is positioned to maintain regional leadership, with Europe and Asia-Pacific contributing expanding research infrastructure. Companies including Cryoport, Azenta, Avantor, and Alcami will compete through technical capabilities, facility reliability, and integrated service offerings. Future growth will depend on energy-efficient equipment, digital traceability, reliable sample handling, and appropriately controlled storage conditions.
Biostorage Service Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 641.39 Million in 2026 |
|
|
Market Size Value By |
USD 2731.72 Million by 2035 |
|
|
Growth Rate |
CAGR of 17.47% from 2026-2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Biostorage Service Market is expected to reach USD 2731.72 Million by 2035.
The Biostorage Service Market is expected to exhibit a CAGR of 17.47% by 2035.
Azenta, Cryoport, Avantor, Precision for Medicine, Masy BioServices (Alcami), Versiti Clinical Trials, MilliporeSigma, SciSafe (BioLife Solutions), Kryosphere, Precision Stability Storage, Vigilant Bioservices, BioStorage, LLC, Tescor
In 2026, the Biostorage Service Market value will reach at USD 641.39 Million.